# Autologous Bone Marrow Derived Stem Cells in Decompensate Cirrhotic Patients

> **NCT01120925** · PHASE1,PHASE2 · COMPLETED · sponsor: **Royan Institute** · enrollment: 30 (actual)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **BIOLOGICAL:** MNC
- **BIOLOGICAL:** CD133
- **BIOLOGICAL:** Control

## Key facts

- **NCT ID:** NCT01120925
- **Lead sponsor:** Royan Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01120925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01120925, "Autologous Bone Marrow Derived Stem Cells in Decompensate Cirrhotic Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01120925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*